Injectable poly(organophosphazene) hydrogel system for effective paclitaxel and doxorubicin combination therapy

Journal of Drug Targeting

Volumn 22, Issue 8, 2014, Pages 761-767

  Cho, Jung Kyo ^a   Kuh, Hyo Jeong ^b   Song, Soo Chang ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cancer chemotherapy; Combination therapy; Controlled release delivery; Drug interaction; Injectable hydrogels; Poly(organophosphazene); Polymeric drug delivery systems

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HYDROGEL; ORGANOPHOSPHORUS COMPOUND; PACLITAXEL; POLY(ORGANOPHOSPHAZENE); POLYMER;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HYDROGEL; MATERIALS TESTING; MOUSE; NEOPLASMS, EXPERIMENTAL; NUDE MOUSE; PROCEDURES; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYDROGELS; MATERIALS TESTING; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; ORGANOPHOSPHORUS COMPOUNDS; PACLITAXEL; POLYMERS; STOMACH NEOPLASMS;

EID: 84905855890     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.921923     Document Type: Article

References (25)

1. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006;58: 621-81.
2. Ramaswamy S. Rational design of cancer-drug combinations. New Engl J Med 2007;357: 299-300.
3. Jia J, Zhu F, Ma X, et al. Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 2009;8: 111-28.
4. International WCRF. Stomach cancer is most common in China, Japan and Korea; 2012. Available from: http://wwwwcrforg/cancer-facts/stomach-cancer- china-japan-koreaphp 2012 [last accessed 16 Jan 2012].
5. National Cancer Institute. Institute NC drugs approved for stomach (gastric) cancer; 2011. Available from: http://www.cancer.gov/cancertopics/ druginfo/stomachcancer [last accessed 16 Jan 2012].
6. Howland RD, Mycek MJ. Pharmcology. In: Harvey RA, Champe PC, eds. Lippincott's illustrated reviews. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006: 466.
7. Sharma A, Straubinger RM. Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm Res 1994;11: 889-96.
8. Li Y, Rodrigues J, Tomas H. Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. Chem Soc Rev 2011;41: 2193-221.
9. Ruel-Gariepy E, Leroux JC. In situ-forming hydrogels - review of temperature-sensitive systems. Eur J Pharm Biopharm 2004;58: 409-26.
10. Nguyen MK, Lee DS. Injectable biodegradable hydrogels. Macromol Biosci 2010;10: 563-79.
11. Park MH, Joo MK, Choi BG, et al. Biodegradable thermogels. Acc Chem Res 2011;45: 424-33.
12. Kim JI, Lee BS, Chun C, et al. Long-term theranostic hydrogel system for solid tumors. Biomaterials 2012;33: 2251-9.
13. Cho JK, Hong KY, Park JW, et al. Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly(organophosphazene) hydrogel. J Drug Target 2011;19: 270-80.
14. Al-Abd AM, Hong KY, Song SC, et al. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release 2010;142: 101-7.
15. Lee SM, Chun CJ, Heo JY, et al. Injectable and thermosensitive poly(organophosphazene) hydrogels for a 5-fluorouracil delivery. J Appl Polym Sci 2009;113: 3831-9.
16. Kang GD, Cheon SH, Song SC. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels. Int J Pharm 2006;319: 29-36.
17. Yoon S-A, Choi JR, Kim J-O, et al. Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity. Cancer Res Treat 2010;42: 163-71.
18. Chung W-H, Sung BH, Kim S-S, et al. Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro. Int J Oncol 2009;34: 1669-79.
19. Kano Y, Akutsu M, Tsunoda S, et al. Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro. Cancer Chemoth Pharm 2004; 54: 505-13.
20. Gordon Steel G, Peckham MJ. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol 1979;5: 85-91.
21. Kim JH, Lee JH, Kim KS, et al. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts. Arch Pharm Res 2013;36: 94-101.
22. Cho JK, Hong JM, Han T, et al. Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment. J Drug Target 2013;21: 564-73.
23. Cho JK, Park JW, Song SC. Injectable and biodegradable poly(organophosphazene) gel containing silibinin: its physicochemical properties and anticancer activity. J Pharm Sci 2012;101: 2382-91.
24. Chemical Book Chemical Book. Chemical book: doxorubicin hydrochloride; 2010. Available from: http://www.chemicalbook.com/ChemicalProductProperty-EN- CB0110633.htm [last accessed 11 Mar 2014].
25. Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002;235: 179-92.